Breakthrough In-Office Ear Tube Solution From Tusker Medical Receives FDA Approval
04 déc. 2019 11h43 HE
|
Tusker Medical
Tula System Offers ENTs, Patients and Parents an Option Without the Operating Room Menlo Park, CA, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tusker® Medical today announced United...
Otonomy to Present at the J.P. Morgan Healthcare Conference
02 janv. 2019 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference
15 nov. 2018 08h30 HE
|
Otonomy, Inc.
SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David...
Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update
05 nov. 2018 16h12 HE
|
Otonomy, Inc.
Conference call and webcast today at 4:30 p.m. EST Conference call will include review of OTO-413 program selected as "Hot Topic" at Society for Neuroscience Annual Meeting SAN DIEGO, Nov. 05, 2018...
Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update
24 févr. 2017 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update
04 août 2016 16h09 HE
|
Otonomy, Inc.
SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
03 sept. 2014 08h00 HE
|
Otonomy, Inc.
SAN DIEGO, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...